Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Turquoise, the LSE and the Fragulator

I was wondering the other day whether we might run out of space on the web site soon as more and more venues are created. Well, the good news is that Xavier Rolet and Eli Lederman may have helped us solve that problem (LSE in talks to buy Turquoise).

Assuming that the proposed acquisition does indeed go ahead, it will be interesting to see how this will affect the trading landscape. What will happen to the liquidity currently residing in Turquoise? Will the LSE want to reinstate the original Liquidity Provision agreements? How will Turquoise interact with Baikal, from both a technology and a personnel perspective?

It’s too early to tell just yet but it is clear to see that the LSE is making sure it has plenty of new pieces on the board, which has to be a good thing. Also, it will help the LSE in its desire to align itself more closely with the interests of its biggest customers as they are also Turquoise’s current owners. And, of course, it will give the LSE a European shop front that it can open tomorrow. It did strike me, though, that the LSE’s approach can be contrasted with that of NYSE Euronext, which Jeremy Grant and Michael Mackenzie wrote about in FT Trading room on Tuesday (NYSE Euronext bets on ‘co-location’ centres). In the article, they describe how NYSE Euronext is investing huge sums of money in co-location facilities both in London and New York. This will be combined with its UTP network that ultimately aims to provide a single point of access regardless of what you want to trade, where or how.

Back at Fidessa Towers we have been ringing the changes, too, with the launch of the Fragulator which allows you to see the trading pattern of any stock over any time period across both lit and dark venues. The clever chaps back at Fidessa Labs have spent the summer working on this and you can see the results of their efforts by clicking here or on the Fragulator tab from the home page. Simply enter any European stock name (the system will prompt you with suggestions as you type), hit the “show report” button and hey presto!

You will also see this icon  next to any stock that appears on the regular site. Clicking on this icon will enable you to fragulate any stock.

The guys have assured me that the interface is idiot proof (which is a bit strange because they were very insistent that I spent a lot of time testing it) but please let us have your feedback and suggestions for what else you would like to see.

Try comparing the VWAPs or Average Trade Sizes between the different types of execution venue – you might get a few surprises. To change the granularity of the report simply hit the “show more” or “show less” buttons. If you want to extend the time period (we currently have 12 months’ worth of data) then log in by entering your email address and a password of your choice. Don’t worry, it’s still free and you will only have to do this once.

As always my thanks go the guys at Fidessa Labs for making it all possible.

One Response to “Turquoise, the LSE and the Fragulator”
  1. Mike Williamson says:

    I’ve been a big fan of FFI for a while now, but the Fragulator is just amazing. Tremendous insight into the state of the market, with beautiful presentation. Thanks!

    One quick question. In the OTC reporting category, what’s the difference between “LSE” and “LSE xoff”? Which of those venues would include trades reported from Fidessa ETP to the LSE?



Leave a comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.